Form 4 Filing: Meehan Viola Mong Acquires (Grant) shares of $CUE
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Meehan Viola Mong, holds the title of Director at Cue Biopharma, Inc..
On 2026-05-30, the insider transacted 1,626 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
**Transaction:** grant of 1,626 shares by Meehan Viola Mong (Director). **Strategic Implications (Investor Edge):** This filing is routine compensation and provides no actionable signal for investors. Director grants are typically pre-scheduled and do not indicate bullish or bearish views on the stock. **Key Takeaways:** - Transaction is a grant, not an open market trade. - Insider is a Director, not a C-suite executive. - No cash value or price per share disclosed, indicating a non-cash equity award.
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.